|Mr. Trevor Anthony Peters||Pres, CEO & Director||275.19k||N/A||1977|
|Mr. Travis Doupe||Chief Financial Officer||242.33k||N/A||1972|
|Dr. Chris Savile||Chief Operations Officer||354.17k||N/A||N/A|
|Mr. Troy T. Talkkari||VP of Corp. Devel.||172.51k||N/A||N/A|
|Dr. Mathias Maximilian Schuetz||VP of Plant Science||144.99k||N/A||N/A|
|Mr. Christopher Speed||Sr. VP of Sales & Marketing||N/A||N/A||N/A|
|Mr. Sanjib Gill||Corp. Sec.||N/A||N/A||1977|
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.
Willow Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.